← Open Payments lookup

MICHELLE BRANNAN: Open Payments

NPI 1588096028 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,280 in 95 payments from 22 companies in 2025. Trend: 2023 $3,610 · 2024 $2,422 · 2025 $2,280

Food & beverage: $2,180Education: $100
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation14$395
Regeneron Healthcare Solutions, Inc.9$253
GENZYME CORPORATION8$246
ABBVIE INC.8$191
Ortho Dermatologics, a division of Bausch Health US, LLC11$155
Galderma Laboratories, L.P.9$152
Incyte Corporation5$133
SANOFI-AVENTIS U.S. LLC1$100
Amgen Inc.5$96
LEO Pharma Inc.5$94

Products named: DUPIXENT, COSENTYX, Cabtreo, NEMLUVIO, OPZELURA, Rhapsido, SKYRIZI, OTEZLA.

Industry payments across TX — which companies pay providers there.